About

Leila N Hassani, PhD, is at Roche. Before that, she was Pharmaceutical Development Project Leader in the Novel Drug Delivery Technologies group at Ipsen, acting as technology scout and scientific lead in projects applying innovative novel drug delivery technologies across the company’s portfolio of peptides and biologics. Before joining Ipsen she earned her PhD in pharmaceutical technologies from the University of Angers, France, where she investigated protein and growth factors encapsulation using supercritical carbon dioxide process. Results generated from her research activities have been published in peer-reviewed journals.